Intradermal sex hormone desensitization for relief of premenstrual symptoms may improve the obstetric outcome of women with recurrent pregnancy loss

Gynecological Endocrinology

Volumn 29, Issue 2, 2013, Pages 169-172

  Itsekson, Alek M ^a   Soriano, David ^a,b   Zolti, Mattityahu ^a   Seidman, Daniel S ^a,b   Carp, Howard J A ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hormone hypersensitivity; Preconceptual desensitization; Premenstrual syndrome; Recurrent pregnancy loss

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; PROGESTERONE; SEX HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DESENSITIZATION; DISEASE SEVERITY; FEMALE; HUMAN; LIVE BIRTH; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RECURRENT PREGNANCY LOSS; SKIN TEST; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; AUTOIMMUNE DISEASES; COHORT STUDIES; DESENSITIZATION, IMMUNOLOGIC; EMBRYO LOSS; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; INJECTIONS, INTRADERMAL; LIVE BIRTH; LONGITUDINAL STUDIES; PREGNANCY; PREMENSTRUAL SYNDROME; PROGESTERONE; PROSPECTIVE STUDIES; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84871441756     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.730582     Document Type: Article

References (32)

1. Raghupathy R, Al-Mutawa E, Al-Azemi M, Makhseed M, Azizieh F, Szekeres-Bartho J. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol 2009;80:91-99.
2. Wojnarowska F, Greaves MW, Peachey RD, Drury PL, Besser GM. Progesterone-induced erythema multiforme. J R Soc Med 1985;78:407-408. (Pubitemid 15109152)
3. Stephens CJ, Wojnarowska FT, Wilkinson JD. Autoimmune progesterone dermatitis responding to Tamoxifen. Br J Dermatol 1989;121:135-137. (Pubitemid 19177131)
4. Shelley WB, Shelley ED, Talanin NY, Santoso-Pham J. Estrogen dermatitis. J Am Acad Dermatol 1995;32:25-31.
5. Yotsumoto S, Shimomai K, Hashiguchi T, Uchimiya H, Usuki K, Nishi M, Kanekura T, Kanzaki T. Estrogen dermatitis: a dendritic-cellmediated allergic condition. Dermatology (Basel) 2003;207:265-268.
6. Itsekson A, Lazarov A, Cordoba M, Zeitune M, Abraham D, Seidman DS. Premenstrual syndrome and associated skin diseases related to hypersensitivity to female sex hormones. J Reprod Med 2004;49:195-199. (Pubitemid 38405784)
7. Halbreich U, Backstrom T, Eriksson E, O'brien S, Calil H, Ceskova E, Dennerstein L, et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 2007;23:123-130. (Pubitemid 46570210)
8. O'Brien PM, Bäckström T, Brown C, Dennerstein L, Endicott J, Epperson CN, Eriksson E, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 2011;14:13-21.
9. Farage MA, Berardesca E, Maibach HI. The effect of sex hormones on irritant and allergic response: possible relevance for skin testing. Br J Dermatol 2009;160:450-451.
10. Mabray CR, Burditt ML, Martin TL, Jaynes CR, Hayes JR. Treatment of common gynecologic-endocrinologic symptoms by allergy management procedures. Obstet Gynecol 1982;59:560-564. (Pubitemid 12150359)
11. Osofsky HJ, Blumenthal SJ (editors). Premenstrual syndrome: current findings and future directions. Washington: American Psychiatric Press; 1985. pp 88.
12. Carp HJA. Investigation and treatment for recurrent pregnancy loss. In: Rainsbury P, Vinniker D. A practical guide to reproductive medicine. Lancaster: Parthenon & Co; 1997.
13. Li TC, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002;8:463-481. (Pubitemid 35175207)
14. Daya S, Gunby J. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group. Am J Reprod Immunol 1994;32:294-302.
15. Craig M, Tata P, Regan L. Psychiatric morbidity among patients with recurrent miscarriage. J Psychosom Obstet Gynaecol 2002;23:157-164. (Pubitemid 35252687)
16. Sugiura-Ogasawara M, Furukawa TA, Nakano Y, Hori S, Aoki K, Kitamura T. Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Hum Reprod 2002;17:2580-2584. (Pubitemid 35174107)
17. Cheng H. Dysmenorrhea, menorrhagia, premenstrual syndrome, and immunologic screening in habitual abortion. Curr Opin Obstet Gynecol 1990;2:840-849.
18. Shakhar K, Rosenne E, Loewenthal R, Shakhar G, Carp H, Ben-Eliyahu S. High NK cell activity in recurrent miscarriage: what are we really measuring? Hum Reprod 2006;21:2421-2425. (Pubitemid 44530622)
19. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten I. Peripheral natural killer cytotoxicity and CD56(pos)CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000;15:1163-1169. (Pubitemid 30251319)
20. Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999;14:2727-2730. (Pubitemid 29520681)
21. Prieto-Garcia A, Sloane DE, Gargiulo AR, Feldweg AM, Castells M. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril 2011;95:1121.e9-1121.13.
22. Seidman DS, Itsekson A, Alesker M, Zolti M, Carp H, Wolman I. Estradiol valerate as a possible endocrine reproductive disruptor: evidence from an in vivo rat model. Fertil Steril 2009;91:1510-1512.
23. Krahn-Bertil E, Dos Santos M, Damour O, Andre V, Bolzinger MA. Expression of estrogen-related receptor beta (ERRß) in human skin. Eur J Dermatol 2010;20:719-723.
24. Pelletier G, Ren L. Localization of sex steroid receptors in human skin. Histol Histopathol 2004;19:629-636. (Pubitemid 38443918)
25. Deng Y, Winter G, Myschik J. Preparation and validation of a skin model for the evaluation of intradermal powder injection devices. Eur J Pharm Biopharm 2012;81:360-368.
26. Puder JJ, Blum CA, Mueller B, De Geyter Ch, Dye L, Keller U. Menstrual cycle symptoms are associated with changes in low-grade inflammation. Eur J Clin Invest 2006;36:58-64.
27. Gupta S, Sekhon L, Kim Y, Agarwal A. The role of oxidative stress and antioxidants in assisted reproduction. Curr Womens Health Rev 2010;6:227-238.
28. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001;3:CD002124.
29. Tu CH, Niddam DM, Chao HT, Chen LF, Chen YS, Wu YT, Yeh TC, et al. Brain morphological changes associated with cyclic menstrual pain. Pain 2010;150:462-468.
30. Baeck M, Marot L, Nicolas JF, Pilette C, Tennstedt D, Goossens A. Allergic hypersensitivity to topical and systemic corticosteroids: a review. Allergy 2009;64:978-994.
31. Degen GH, Bolt HM. Endocrine disruptors: update on xenoestrogens. Int Arch Occup Environ Health 2000;73:433-441.
32. Inadera H. The immune system as a target for environmental chemicals: Xenoestrogens and other compounds. Toxicol Lett 2006;164:191-206. (Pubitemid 43766790)